Barely Significant
← all excerpts

Impact of treatment interruption on the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis: a <i>post-hoc</i> analysis of a phase 3 trial.

Front Immunol · 2025 · PMC12855095 · PMID 41624863

Europe PMCDOI
2
hedged sentences
0.0010
closest p · 0.0× alpha
0.0070
boldest claim

The sentences

an increasing trendP <0.001actually significant
Subgroup analysis for PROs At W52, the mean DLQI score showed an increasing trend with the increase in times of treatment interruption ( P <0.001), and achievement rates for DLQI 0/1 showed a decreasing trend ( P =0.007).

also in 30,787 other papers

a decreasing trendP =0.007actually significant
Subgroup analysis for PROs At W52, the mean DLQI score showed an increasing trend with the increase in times of treatment interruption ( P <0.001), and achievement rates for DLQI 0/1 showed a decreasing trend ( P =0.007).

also in 24,879 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.